ホーム › 非小細胞肺癌 › ネブラスカ州

ネブラスカ州における非小細胞肺癌の臨床試験

ネブラスカ州内の拠点で、非小細胞肺癌に関する40件の研究が参加者を募集しています。

ネブラスカ州内の都市

公式研究テキスト（英語）

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Nebraska Medicine-Bellevue, Bellevue
Fred and Pamela Buffett Cancer Center - Kearney, Kearney
CHI Health Good Samaritan, Kearney
他5件

被験者募集中第3相

18歳以上 · 全性別 · 2026/10/02更新 · NCT04267848

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Nebraska Hematology-Oncology - Revive Research Institute LLC, Lincoln

被験者募集中第3相

18歳以上 · 全性別 · 2026/10/02更新 · NCT06472245

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Nebraska Cancer Specialists, Grand Island
Oncology Hematology West PC, Omaha

被験者募集中第2相

18歳以上 · 全性別 · 2026/10/02更新 · NCT07680764

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #2, Omaha

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

NHO Revive Research Institute, LLC ( Site 3218), Lincoln

被験者募集中第3相

18歳以上 · 全性別 · 2026/10/01更新 · NCT07513376

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Nebraska Cancer Specialists, Omaha
XCancer, Omaha

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/10/01更新 · NCT07189871

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Nho - Revive Research Institute /ID# 277569, Lincoln

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/10/01更新 · NCT07155187

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

NHO Revive Research Institute LLC ( Site 0118), Lincoln

被験者募集中第3相

18歳以上 · 全性別 · 2026/10/01更新 · NCT07554339

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Nebraska Medicine-Bellevue Medical Center, Bellevue
Nebraska Medicine, Omaha
Nebraska Medicine - Village Pointe, Omaha
他1件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07144280

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NHO Revive Research Institute, LLC, Lincoln
NHO Support Center, Lincoln
Cancer Partners of Nebraska, Lincoln

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT07222566

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Cancer Partners of Nebraska, Lincoln

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/25更新 · NCT07489066

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Oncology Hematology West, PC dba Nebraska Cancer Specialists - Fremont, Fremont
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island, Grand Island
Oncology Hematology West, PC dba Nebraska Cancer Specialists - Regional, Grand Island
他5件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06758401